bpc-157 tga approval status Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance | Sports Medicine BPC-157 - Wikipedia

The proposed mechanism involves potentiation of existing opioid tone rather than direct opioid receptor agonism, which may explain the absence of classical tolerance and dependence patterns

U.MoarefiI

[1] [2] Elevated methylmalonic acid levels may also indicate a deficiency

You may have several options when it comes to treatment, one of them being orthobiologics

31 Moreover, a randomized, placebo-controlled multicenter trial (J-REPAIR) investigating the use of allogeneic human dental pulp stem cells for the treatment of acute ischemic stroke indicated that DPSC therapy was not associated with significant toxicity or major adverse events during the treatment period